Mathew R. Stamper
Founder & Director
Mathew R. Stamper is the founder and director of Stamper Lab LLC.
His academic training spans epidemiology, clinical research methodology, medical anatomy, and systems physiology. He has completed advanced training in epidemiology and clinical research through Stanford University School of Medicine and in medical anatomy and physiology through University of Florida College of Medicine. This work emphasizes quantitative study design, translational reasoning, and structural understanding of biological systems, with a consistent focus on how dysfunction emerges under stress rather than how it is summarized at endpoints.
His scientific development has been shaped by training across multiple academic environments within the University of Colorado system, including CU Denver, CU Boulder, and the Anschutz Medical Campus, where he completed post-baccalaureate premedical study and developed applied laboratory and research fluency. During his undergraduate time at Arizona State University, his studies concentrated on physiology, population health, and applied biomedical science, forming the foundation for later systems-level and translational work.
Stamper Lab was founded in Fall 2024 as an independent biomedical research organization.
The lab conducts applied research focused on direct biological observation, mechanistic clarity, and long-horizon work that compounds through method rather than scale.
Mechanism first investigation across cellular, tissue, and organ levels. Development of experimental and computational methods to resolve how biological systems function, break down, and can be intervened upon.
RESEARCH & DEVELOPMENT FOCUS
Biological Mechanism & System Failure
Investigation of how biological systems function, compensate, and ultimately fail across cellular, tissue, and organ levels. Work centers on identifying causal mechanisms with attention to structure, dynamics, and functional breakdown across disease contexts including neurodegeneration, cardiovascular disease, cancer, immune dysfunction, and aging.
Disease Relevant Experimental
Models
Development and use of experimental systems that preserve biological complexity and enable meaningful interpretation of dysfunction. Current model systems include yeast, synthetic membranes, and environmental stressor assays, selected to study real biological behavior over time with full mechanistic resolution.
Neurobiology, Vascular Biology & Chronic Disease
Study of neurological, cerebrovascular, and chronic disease processes as interconnected systems. Emphasis on how structural, metabolic, inflammatory, and signaling mechanisms interact to drive progression. Active areas include Alzheimer's disease, Parkinson's disease, stroke and small vessel disease, and the mechanistic relationship between vascular health and brain tissue integrity.
Microbial Systems & Adaptive Biology
Investigation of microbial survival, adaptation, and resistance under selective pressure. Laboratory research on drug resistant pathogens, resistance acquisition, and the biological conditions that enable persistence. Microbial systems serve as interpretable models of system level adaptation with direct relevance to broader biological inquiry.
Computational Biology & Biotechnology Development
Design and development of computational and generative biology platforms to support hypothesis generation, mechanistic inference, and integration of experimental data. Includes DOXLAS, a biotechnology platform built to unify biological observation, molecular modeling, and predictive analysis within a single research workflow..
Stamper Lab operates as a hybrid between an academic research group, a translational incubator, and a technical platform. Microscopy, biochemical assays, statistical modeling, and computational tooling coexist in the same workflow, positioned upstream of clinical application and downstream of pure theory.
Research begins with direct biological observation. Microscopy, fluorescence imaging, and controlled experimental measurement generate the primary data that inform every downstream question. Models are selected to preserve complexity and enable full mechanistic interpretation.
The scope is organized around mechanism. Neurobiology connects to vascular biology through shared structural and metabolic pathways. Microbial adaptation provides a parallel lens on robustness and failure. Epidemiologic reasoning shapes experimental design directly. Every line of inquiry resolves to the same structural question: how biological systems function, how they compensate, and how they fail.
Programs run on long timelines and are structured around sustained investigation of defined biological questions.
APPROACH
CORE CAPABILITES
Microscopy & Imaging
Light and fluorescence microscopy for cellular and subcellular imaging of structural integrity, functional markers, and damage progression across experimental model systems.
Biochemical & Redox Analysis
Experimental characterization of oxidative dynamics, antioxidant behavior, and biochemical pathway activity in synthetic and biological systems.
Microbial & Antimicrobial Systems
Laboratory investigation of pathogen resistance, adaptive survival, and microbial behavior under selective pressure. Integrated into the broader mechanistic research framework.
Computational & Generative Modeling
Generative AI, molecular modeling, and algorithmic analysis applied to target identification, pathway inference, and data integration. Includes proprietary biotechnology platform development.
Translational Integration
The capacity to move between bench observation, computational analysis, and clinical framing within a single research program. The distinguishing operating capability of the lab.
Epidemiology & Study Design
Quantitative research methodology, biostatistical analysis, and epidemiological frameworks applied to experimental design and translational interpretation.
WHAT WE WORK ON
WHAT WE WORK ON
Contact us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!